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OBJECTIVES We sought to determine the relationship between exercise duration and cardiovascular
outcomes in patients with profound ($2 mm) ST segment depression during exercise
treadmill testing (ETT).
BACKGROUND Patients with stable symptoms but profound ST segment depression during ETT are often
referred for a coronary intervention on the basis that presumed severe coronary artery disease
(CAD) will lead to unfavorable cardiovascular outcomes, irrespective of symptomatic and
functional status. We hypothesized that good exercise tolerance in such patients treated
medically is associated with favorable long-term outcomes.
METHODS We prospectively followed 203 consecutive patients (181 men; mean age 73 years) with
known stable CAD and $2 mm ST segment depression who are performing ETT according
to the Bruce protocol for an average of 41 months. The primary end point was occurrence of
myocardial infarction (MI) or death.
RESULTS Eight (20%) of 40 patients with an initial ETT exercise duration #6 min developed MI or
died, as compared with five (6%) of 84 patients who exercised between 6 and 9 min and three
(3.8%) of 79 patients who exercised $9 min (p 5 0.01). Compared with patients who
exercised #6 min, increased ETT duration was significantly associated with a reduced risk of
MI/death (6 to 9 min: relative risk [RR] 5 0.25, 95% confidence interval [CI] 0.08 to 0.76;
.9 min: RR 5 0.14, 95% CI 0.04 to 0.53). This protective effect persisted after adjustment
for potentially confounding variables. We observed a 23% reduction in MI/death for each
additional minute of exercise the patient was able to complete during the index ETT.
CONCLUSIONS Optimal medical management in stable patients with CAD with profound exercise-induced
ST segment depression but good ETT duration is an appropriate alternative to coronary
revascularization and is associated with low rates of MI and death. (J Am Coll Cardiol 2000;
36:2140–5) © 2000 by the American College of Cardiology
Profound ST segment depression provoked by exercise tread-
mill testing is predictive of significant multivessel coronary
artery disease (CAD) (1–6). These patients are often referred
for coronary angiography and subsequent revascularization,
irrespective of symptoms, on the basis that reducing the extent
of ischemic burden may improve long-term outcomes. In the
present longitudinal study, we have attempted to define the
natural history of medically managed patients with stable CAD
who exhibited profound ST segment depression during stan-
dard Bruce protocol exercise treadmill testing (ETT). Our
hypothesis was that increased exercise duration was positively
associated with improved outcomes in medically managed
patients with significant CAD.
METHODS
A total of 203 patients (181 men, average age 73 years) with
CAD and $2 mm planar or downsloping ST segment
depression who performed ETT according to the Bruce
protocol were prospectively followed for an average of 41
months. Baseline data regarding medical history and the use
of cardiac medications were obtained by questionnaire at the
initial clinic visit. Coronary artery disease was defined by
coronary angiography, documented previous myocardial
infarction (MI) or the combination of typical ischemic
symptoms and a positive noninvasive test for CAD or
ischemia. Patients with New York Heart Association
(NYHA) functional class III or IV congestive heart failure
(CHF), unstable coronary syndromes or baseline electrocar-
diographic (ECG) abnormalities that would make the
treadmill test nondiagnostic (i.e., left bundle branch block
[LBBB], nonspecific intraventricular conduction abnormal-
ity, nonspecific ST segment abnormalities [resulting in ST
segment shift $0.5 mm], $0.5 mm ST segment depression
with hyperventilation and digoxin therapy before testing)
were excluded.
All patients exercised on a motorized treadmill according
to the standard Bruce protocol until the point of exhaustion,
unless one of the following developed: 1) progressive angina
(increasing, subjective, typical pain resulting in the patient’s
desire to stop exercise); 2) signs of peripheral hypoperfusion
(pallor, clammy skin, glazed look) and/or profound exer-
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tional hypotension (,10 mm Hg decrease in systolic blood
pressure as compared with pretest standing, posthyperven-
tilation blood pressure); 3) development of sustained ven-
tricular arrhythmias (.10 consecutive beats or by physi-
cian’s discretion); or 4) the patient’s reluctance to continue.
Profound ($2 mm) shifts in ST segment depression, a
calculated “peak heart rate” (PHR 5 220 2 age), and a
predetermined time limit were not indications for stopping
the test. The patient’s exercise duration and follow-up were
based on the index treadmill test with profound ST segment
depression. The study group was subclassified into three
groups on the basis of their exercise duration (,6 min, 6 to
9 min and .9 min) to broadly identify patients with poor,
moderate, and superior exercise tolerance, respectively.
Criteria for cardiac catheterization and consideration for
revascularization included: 1) cardiac arrest/primary ventric-
ular fibrillation; 2) pulmonary edema of potentially ischemic
etiology; 3) intolerance of, or noncompliance with, medical
therapy; 4) mandate of job description (e.g., pilot, bus
driver); or 5) decreased left ventricular function by echocar-
diography with clinical evidence of ischemia.
The primary end point of this observational study was the
development of MI or death. Secondary end points were the
occurrence of unstable angina (accelerated chest pain [or
equivalent] syndrome with rest or nocturnal symptoms or
symptoms with very limited exertion), CHF (NYHA func-
tional class IV requiring change in treatment or hospital
admission), ventricular tachycardia (any repetitive ventricu-
lar rhythm .100 beats/min resulting in symptoms [e.g.,
syncope, presyncope, or chest pain, or lasting .30 s]) or
coronary revascularization. “Optimal medical therapy” in
this investigation was achieved by placing emphasis on the
widespread use of beta-blockers, aspirin and hydroxymethyl
glutaryl coenzyme A (HMG-CoA) reductase inhibitors in
the study group, with supplementation of long-acting and
sublingual nitrates and calcium channel blockers, as neces-
sary to control symptoms. Beta-blockers in our practice
setting were titrated to maintain the rest heart rate #60
beats/min and to attenuate the chronotropic response on
subsequent exercise testing. Our statin therapeutic targets
included total serum cholesterol #180 mg/dl and low
density lipoprotein cholesterol #100 mg/dl. Long-acting
nitrates and calcium channel blockers were used in patients
with a greater frequency of angina. The long-acting nitrates
were timed to be temporally effective with anticipated
symptoms. Sublingual nitroglycerin was encouraged pro-
phylactically for activities anticipated to precipitate angina
in this cohort of patients.
Patients in this study were seen on follow-up visits every
six months subsequent to the index ETT and were evaluated
by history, physical examination and yearly echocardio-
grams. Hospital records were obtained for independent
verification in patients who experienced primary or second-
ary study end points. At least one year of follow-up data
were obtained in all patients included in this study (unless
an end point occurred before one year).
Data analysis. Demographic and clinical characteristics
and the occurrence of study end points in patients with
stable, medically managed CAD further categorized accord-
ing to strata of exercise duration were evaluated by using the
Fisher exact test to compare categoric variables and the
Student t tests to compare continuous variables. All tests of
statistical significance were two-tailed at p , 0.05. Multi-
variable Cox regression models were used to examine the
association of the primary study end points to exercise
duration, while controlling for potentially confounding
demographic, historic and clinical variables. These variables
included age, gender and a history of hypertension, diabetes,
MI or revascularization.
RESULTS
The study group consisted of a largely middle to upper
socioeconomic class Caucasian population (average age 73
years) from the northeastern United States. Sixty-five per-
cent of this study group was referred for second opinion
regarding the need for coronary revascularization. Individ-
uals who were able to exercise for a longer time on the index
ETT included a greater proportion of men and individuals
without a history of hypertension and diabetes (Table1).
The rates of coronary revascularization were 26%, 17% and
Abbreviations and Acronyms
CAD 5 coronary artery disease
CHF 5 congestive heart failure
CI 5 confidence interval
ECG 5 electrocardiographic or electrocardiogram
ETT 5 exercise treadmill test
HMG-CoA 5 hydroxymethyl glutaryl coenzyme A
LBBB 5 left bundle branch block
MI 5 myocardial infarction
NYHA 5 New York Heart Association
PHR 5 peak heart rate
RR 5 relative risk
Table 1. Baseline Characteristics
Exercise Duration
<6 Min
(n 5 40)
6–9 Min
(n 5 84)
>9 Min
(n 5 79)
Mean age (years) 79 73 69
Male gender 80% 85% 99%
Medical history
Myocardial infarction 28% 31% 25%
Angina 68% 62% 58%
Diabetes 27% 13% 5%
Hypertension 60% 51% 43%
Smoking 66% 56% 64%
Ventricular tachycardia 0% 0% 1.3%
Medications
Nitroglycerin 49% 51% 46%
Beta-blocker 85% 85% 71%
Calcium channel blocker 63% 68% 58%
Lipid-lowering therapy 34% 51% 51%
Aspirin 90% 92% 94%
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19%, respectively, for patients who were able to exercise for
,6 min, 6 to 9 min and .9 min.
The mean PHR was 122 beats/min; the mean peak
(systolic) blood pressure was 149 mm Hg; and the median
ST segment depression was 2.5 mm Hg for the study group
during ETT according to the Bruce protocol. Thirty-one of
the patients (15.3%) stopped the exercise test because of
angina pectoris. Of these 31 patients, 10 (33%) exercised for
,6 min;15 (48.4%) for 6 to 9 min; and 6 (19.4%) for
.9 min (p 5 0.04). Use of beta-blockers, calcium channel
blockers and nitroglycerin was declined with progressively
higher levels of peak exercise performance at the time of
baseline studies (Table 1).
The overall event rate of MI and/or death was low in the
study group. The overall death rate was 3.9%, or an
annualized mortality rate of 1.1%, for the entire study
group. The incidence of the primary end point—death or
nonfatal MI—was 20% in the #6-min group; 6% in the 6-
to 9-min group; and 3.8% in the $9 min group (p 5 0.01)
(Fig. 1). Compared with the baseline #6-min group,
increased ETT duration was significantly associated with a
reduced risk of MI/death (6 to 9 min: relative risk [RR] 5
0.24, 95% confidence interval [CI] 0.08 to 0.76; .9 min:
RR 5 0.14, 95% CI 0.04 to 0.53). After adjusting for
varying durations of follow-up and previously described
potential prognostic confounders in a Cox regression model,
the protective effect of increased ETT duration persisted
(Table 2). Patients who were able to exercise for 6 to 9 min
and .9 min were at 68% and 72% reduced risk, respectively,
of MI/death as compared with patients in the referent group
(,6 min) (Table 2). Inclusion of second-opinion referral
status as a baseline covariate in this regression model did not
affect these findings. Furthermore, stopping ETT because
of angina pectoris did not diminish the protective effect of
exercise duration when included in the multivariate model.
When exercise duration was considered as a continuous
variable (after adjusting for varying durations of follow-up,
revascularization and other potential prognostic confound-
ers in a Cox regression model), a 22% reduction (95% CI
0.59 to 1.0) in MI/death was demonstrated for each
additional minute of ETT duration attained (p 5 0.06). In
addition, patients with poorer exercise capacity were more
likely to reach the primary end point earlier, as compared
with those who could perform at a higher work load (Fig.
2). Further adjustments for a history of hypertension and
beta- blocker use did not affect these results. Use of
beta-blockers, calcium channel antagonists and nitrates was
increased among all groups, according to peak exercise
performance, as compared with use of these medications at
baseline enrollment (Table 3).
The incidence of the secondary end points of CHF,
unstable angina and ventricular tachycardia also declined
with increasing peak exercise capacity (Fig. 3).
DISCUSSION
Exercise-induced ST segment depression during treadmill
testing often results in referral for angiography and revas-
cularization, even if the patient has no or minimal symp-
toms and a good hemodynamic response to exercise. How-
ever, considerable evidence exists to suggest that, while
being a predictor of CAD, ST segment depression alone
does not predict the long-term outcomes of patients with
CAD.
This study demonstrates a 22% reduction in the rate of
death or MI per 1-min increment in the duration of ETT
Figure 1. Incidence of MI or death.
Table 2. Crude and Multivariable Adjusted Odds of Developing
Myocardial Infarction or Death Based on Exercise Duration
Crude Odds
Ratio
(95% CI)
Adjusted Odds
Ratio*
(95% CI)
,6 Min 1.0 1.0
6–9 Min 0.25 0.33
(0.08–0.76) (0.09–1.11)
.9 Min 0.14 0.21
(0.04–0.53) (0.04–1.21)
*Adjusted for exercise duration, age, gender, history of revascularization, hyperten-
sion, diabetes and myocardial infarction.
CI 5 confidence interval.
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(Bruce protocol). This finding, which suggests that in-
creased levels of exercise performance are associated with an
improved prognosis, is consistent with the results of previ-
ous investigations (6–16). A previous report from our group
on a different cohort of 143 medically managed patients
with stable symptoms but with profound ST segment
depression on consecutive Bruce protocol exercise treadmill
tests, demonstrated a low incidence of cardiac complications
and a trend toward improved outcomes with increased
exercise tolerance over a follow-up of 59 months (7).
Goraya et al. (8) recently reported that work load was the
only treadmill characteristic associated with all-cause mor-
tality in 514 elderly ($65 years of age) and 2,593 younger
(,65 years of age) patients included in an inception cohort
followed for a mean duration of six years. Morris et al. (9),
in a prospective study of 588 men (mean age 59 years)
referred for evaluation of CAD and followed for an average
of 30 months, failed to observe an association between
exercise-induced ST segment depression and cardiovascular
death or nonfatal MI. Factors associated with a poor
outcome in their study included a history of CHF, the
presence of ST segment depression on the rest ECG and
exertional hypotension. Using these predictors to classify
patients into low, moderate, and high risk subgroups, they
found annual rates of cardiac mortality to be 1%, 7% and
12%, respectively (9). In a prospective study of 595 men who
had undergone exercise treadmill testing and coronary
arteriography and who were followed for an average of 60
months, ST segment depression was significantly associated
with severity of CAD, but was not associated with impaired
long-term survival. History of CHF, reduced left ventricular
function and poor exercise capacity were strong predictors of
long-term survival in this study (6). In a prospective study of
936 patients (mean age 59 years) between one and six
months after their MI or unstable angina, an increased
incidence of adverse outcomes was observed in patients with
symptomatic ischemia and poor exercise tolerance over an
average follow-up of nearly two years (10). Finally, in a
prospective study of 2,546 male veterans (mean age 59
years) followed for 45 months, an association between peak
exercise capacity and clinical cardiovascular outcomes was
observed. In contrast to the previous studies, however, the
degree of exercise-induced ST segment depression was
independently related to poor long-term outcome. Differ-
ences between the results of this study and the previously
described studies may relate, in part, to the inclusion of
patients with clinical CHF or digoxin use, or both, in this
study as compared with others (11).
Maximization of medical therapy is paramount to im-
proving morbidity and mortality in patients with stable
coronary disease. In our cohort, particular emphasis was
given to the use of aspirin, beta-blockade and HMG-CoA
reductase therapies, which have been shown to decrease the
risk of nonfatal MI and death in patients with CAD
(17–23). Long-acting nitrates and calcium channel blockers
were used as supplemental therapy in patients with greater
levels of angina. We emphasized the use of sublingual
nitroglycerin prophylactically for activities anticipated to
produce angina, as well as for pain. The antianginal thera-
pies were individually tailored for the time of day and
situations during which angina was likely to occur.
Study strengths. This study’s strengths include a novel and
contemporary perspective on the natural history of patients
traditionally considered to be at high risk for CAD and
adverse cardiac outcomes in the “modern” medical era in
which aspirin, beta-blockers and statins are widely used.
The prospective design and relatively long duration of
follow-up diminish biases that may be encountered in
retrospective or short-term studies. Other strengths include
the inclusion of women, an older age group and use of
regression analyses to control for potential confounding
variables.
Study limitations. Potential limitations of this study in-
clude the relatively small sample size and low absolute
number of study end points, which is reflected by the
relatively wide 95% CIs on the estimated risks of adverse
outcomes associated with ETT duration. However, the low
Figure 2. Event-free survival based on exercise duration. Solid line5
,6 min; long-dashed line 5 6 to 9 min; short-dashed line 5 .9 min.
Table 3. Medical Management at Last Follow-Up
Medication <6 Min 6–9 Min >9 Min Total
Beta-blocker 88% 87% 74% 83%
Calcium channel blocker 63% 62% 45% 56%
Long-acting nitrates 51% 40% 27% 37%
Diuretics 25% 11% 1% 10%
Lipid-lowering therapy 49% 65% 71% 64%
Aspirin 88% 92% 97% 93%
Data are presented as percentage of patients.
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number of nonfatal MIs and deaths in the overall study
group only further emphasizes that such patients may be
safely managed medically, with decisions about revascular-
ization being based on symptoms and clinical status, rather
than on the degree of ischemia provoked by treadmill
testing. A large percentage of the study group was referred
for a second opinion on cardiac catheterization. This may
reflect a selection bias that could limit the ability to
generalize our findings. However, such referral biases often
favor greater levels of disease rather than less. The variables
in this study included only those tests that were interpret-
able by ECG criteria. Therefore, patients with rest LBBB or
nonspecific intraventricular conduction abnormalities or
those receiving digoxin therapy were excluded from the
study.
Conclusions. On the basis of our findings, patients with
profound ST segment depression provoked by ETT, but
with good exercise tolerance, hemodynamic response and
well-controlled symptoms, can be safely managed medically
with an expectation of low rates of death or nonfatal MI.
The likelihood of these events is inversely proportional to
increased exercise performance on treadmill testing. Revas-
cularization procedures may be safely delayed and often
deferred in such patients.
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